{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:05:58Z","timestamp":1787018758385,"version":"build-2736575974"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>We assessed the influence of dimenhydrinate, cinnarizine and transdermal scopolamine on the ability to perform simulated naval crew tasks. The effect of single doses of dimenhydrinate, 100 mg, cinnarizine, 50 mg, and one transdermal scopolamine patch on psychomotor performance was evaluated using a double-blind, placebo-controlled, randomized, crossover design in three separate studies. A total of 60 young naval crew (20 for dimenhydrinate, 15 for cinnarizine and 25 for transdermal scopolamine) underwent a battery of computerized and paper and pencil performance tests, and filled out a questionnaire on side-effects and well-being self-assessment. Dimenhydrinate significantly impaired decision reaction time and auditory digit span. Most of the subjects who took dimenhydrinate also reported a subjective decrease in well-being and general performance abilities. Cinnarizine and transdermal scopolamine did not affect performance abilities. Cinnarizine was free of significant side-effects. Dry mouth was the only significant side-effect of transdermal scopolamine. These findings could be explained by the well-known sedative properties of dimenhydrinate and not by a specific effect on any particular cognitive or motor function. Our results suggest that dimenhydrinate, 100 mg, adversely affects psychomotor function, whereas single doses of cinnarizine, 50 mg, and transdermal scopolamine appear to be free of side-effects on performance and seem to be a preferable anti-seasickness drug for use by a naval crew.<\/jats:p>","DOI":"10.1177\/026988110101500311","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T19:04:54Z","timestamp":1238612694000},"page":"167-172","source":"Crossref","is-referenced-by-count":58,"title":["The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance"],"prefix":"10.1177","volume":"15","author":[{"given":"C. R.","family":"Gordon","sequence":"first","affiliation":[{"name":"Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, PO Box 8040, 31 080 Haifa, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Nachum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Doweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shupak","sequence":"additional","affiliation":[{"name":"Department of Neurology, Meir General Hospital, Kfar Saba and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"atypb1","first-page":"60","volume":"58","author":"Attias J","year":"1987","journal-title":"Aviat Space Environ Med"},{"key":"atypb2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0031-6997(25)07243-6","volume":"18","author":"Brand J J","year":"1966","journal-title":"Pharmacol Rev"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978234375"},{"key":"atypb4","first-page":"606","volume":"65","author":"Doweck I","year":"1994","journal-title":"Aviat Space Environ Med"},{"key":"atypb5","first-page":"215","volume":"4","author":"Doweck I","year":"1994","journal-title":"J Vestib Res"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428554"},{"key":"atypb7","first-page":"27","volume":"18","author":"Godfraind T","year":"1982","journal-title":"Drugs Today"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1177\/026988118900300401"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1985.tb02867.x"},{"key":"atypb10","first-page":"236","volume":"57","author":"Gordon C","year":"1986","journal-title":"Aviat Space Environ Med"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6682.1220"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3103172.x"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199912050-00004"},{"key":"atypb14","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Hardman J G","year":"1996","edition":"9"},{"key":"atypb15","first-page":"547","volume":"224","author":"Hargreaves J","year":"1980","journal-title":"Practitioner"},{"key":"atypb16","first-page":"160","volume":"226","author":"Hargreaves J","year":"1982","journal-title":"A comparison of cinnarizine with hyoscine. Practitioner"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.0290s3133.x"},{"key":"atypb18","first-page":"994","volume":"54","author":"Homick J L","year":"1983","journal-title":"Aviat Space Environ Med"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1177\/014556139607500408"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130313"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.5.881"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1007\/BF00716383"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120119"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.5.789"},{"key":"atypb25","first-page":"218","volume":"58","author":"Oosterveld W J","year":"1987","journal-title":"Aviat Space Environ Med"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470010209"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1159\/000118371"},{"key":"atypb28","first-page":"1","volume":"60","author":"Parrott A C","year":"1989","journal-title":"Aviat Space Environ Med"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176487"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196232184"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.57"},{"key":"atypb32","volume-title":"Motion sickness","author":"Reason J T","year":"1975"},{"key":"atypb33","volume-title":"The extra pharmacopoeia","author":"Reynolds J E F","year":"1996","edition":"31"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050430"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1159\/000026486"},{"key":"atypb36","volume-title":"The PC\/S Vienna test system","author":"Schuhfried G","year":"1992"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.84"},{"key":"atypb38","first-page":"818","volume":"38","author":"Tang P C","year":"1967","journal-title":"Aerosp Med"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196013280"},{"key":"atypb40","doi-asserted-by":"publisher","DOI":"10.1037\/11167-000"},{"key":"atypb41","series-title":"Contemporary neurology series, 26","first-page":"71","volume-title":"Principles of behavioral neurology","author":"Weintraub S","year":"1985"},{"key":"atypb42","first-page":"343","volume-title":"Motion and space sickness","author":"Wood C D","year":"1989"},{"key":"atypb43","first-page":"1341","volume":"39","author":"Wood C D","year":"1968","journal-title":"Aerosp Med"},{"key":"atypb44","first-page":"310","volume":"56","author":"Wood C D","year":"1985","journal-title":"Aviat Space Environ Med"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988110101500311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988110101500311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:08:19Z","timestamp":1777507699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026988110101500311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1177\/026988110101500311"],"URL":"https:\/\/doi.org\/10.1177\/026988110101500311","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}